# EDGAR Filing Document

**Accession Number:** 0002066836
**File Stem:** 0002137182-26-000001
**Filing Date:** 2026-5
**Character Count:** 5743
**Document Hash:** e4791d377ecc47b9f3c231f96b0e2de6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002137182-26-000001.hdr.sgml**: 20260527

**ACCESSION NUMBER**: 0002137182-26-000001

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260511

**FILED AS OF DATE**: 20260527

**DATE AS OF CHANGE**: 20260527

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Wright Michael G.
- **CENTRAL INDEX KEY:** 0002137182

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43283
- **FILM NUMBER:** 261025144

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 18 VICTOR
- **CITY:** MILLE ISLES
- **PROVINCE COUNTRY:** A8
- **ZIP:** J0R 1A0
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Conexeu Sciences Inc.
- **CENTRAL INDEX KEY:** 0002066836
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1031

**BUSINESS ADDRESS:**
- **STREET 1:** 50 WEST LIBERTY STREET, SUITE 880
- **CITY:** RENO
- **STATE:** NV
- **ZIP:** 89501
- **BUSINESS PHONE:** 604-315-4722

**MAIL ADDRESS:**
- **STREET 1:** 50 WEST LIBERTY STREET, SUITE 880
- **CITY:** RENO
- **STATE:** NV
- **ZIP:** 89501

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Wright Michael G.<br><sub>(Last) (First) (Middle)</sub><br>18 VICTOR<br><sub>(Street)</sub><br>MILLE ISLES,  J0R 1A0<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Conexeu Sciences Inc. [ CNXU ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-05-11 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 750000 | D |  |
| Common Stock | 1498048 | I | N3GU Investments LLC<sup>(1)</sup> |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Stock Options (Right to Buy) | 2025-06-09<sup>(2)</sup> | 2030-06-09 | Common Stock | 50000 | $0.4 | D |  |
| Warrants | 2025-01-21<sup>(3)</sup> | 2027-01-21 | Common Stock | 78595 | $0.8 | I | N3GU Investments LLC<sup>(1)</sup> |
| Performance Warrants | <sup>(4)</sup> | 2030-06-05 | Common Stock | 900000 | $0.001 | I | N3GU Investments LLC<sup>(1)</sup> |

---

### Footnotes:

(1) The reported securities are held directly by N3GU Investments LLC, a Wyoming limited liability company, over which the Reporting Person has sole voting and dispositive power.

(2) The Stock Options were granted on June 9, 2025 and vested immediately upon the grant date.

(3) The Warrants were granted on January 21, 2025 and vested immediately upon the grant date.

(4) The Performance Warrants were granted on June 5, 2025. 150,000 Performance Warrants have vested. The remainder of the Performance Warrants will vest and be exercisable upon the following milestone events: (i) 250,000 Performance Warrants upon the Issuer's listing its shares of common stock on a recognized stock exchange in North America; (ii)  250,000 Performance Warrants upon the Issuer's listed shares of common stock trading for at least 20 consecutive trading days at a market capitalization of >$80,000,000 in the currency of the recognized stock exchange in North America on which the shares of common stock are listed; and (iii) 250,000 Performance Warrants upon the Issuer's submitting a 510(k) application to the United States Food and Drug Administration.

**Signature:** Wright Michael G.  
**Date:** 2026-05-27

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**